Abstract:Objective:To explore the relationship between lung cancer tumor-related markers and polymyositis/dermatomyositis (PM/DM) complicated with interstitial lung disease (ILD), so as to discover the specific serum markers related to PM/DM rapid progress interstitial lung disease (RPILD).Methods:This was a case-control study.A total of 171 adult PM/DM-ILD patients including 28 cases of RPILD and 143 cases of non-RPILD were admitted to the Affiliated Drum Tower Hospital of Nanjing University Medical School between February 2016 and February 2019.The clinical characteristics, serum levels of different lung cancer tumor markers, inflammation indicators, lung function indicators, etc.of each research subject were obtained from the patients′ medical files on admission and during follow-up telephone calls.The differences in clinical characteristics and lung cancer tumor marker levels were compared between RPILD and Non-RPILD.Through logistic regression analysis, we obtained the variables related to the occurrence of RPILD.The receiver operating characteristic (ROC) was used to analyze the sensitivity and specificity of different variables related to RPILD.The independent Mann-whitney U test and χ2 test were used for comparison between groups. Results:The positive rate of anti-melanoma differentiation-associated gene 5 (MDA5) antibody was higher in RPILD patients [93% (26/28) vs 33% (47/143), P<0.001].Compared with PM/DM Non-RPILD patients, PM/DM RPILD patients had elevated levels of CEA [7.1 μg/L (2.6, 12.9) μg/L vs 1.9 μg/L (0.9, 3.6) μg/L, Z=4.06, P<0.001], CYFRA21-1 [8.4 μg/L (5.6, 16.0) μg/L vs 4.4 μg/L (3.0, 7.5) μg/L, Z=3.66, P<0.001], NSE [25.6 μg/L (15.9, 28.4) μg/L vs 16.4 μg/L (13.9, 20.8) μg/L, Z=3.66, P<0.001], LDH [455.0 U/L (352.8, 602.8) U/L vs 287.0 U/L (237.0, 386.0) U/L, Z=4.65, P<0.001] and CRP [20.4 mg/L (8.7, 44.9) mg/L vs 6.1 mg/L (3.2, 19.7) mg/L, Z=4.06, P<0.001], peripheral blood lymphocyte subset analysis demonstrated that the proportion of CD3 + CD4 + T cells [18.9% (10.5%, 28.1%] vs 39.5%(24.5%, 59.8%), Z=4.80, P<0.001] and the oxygenation index [187.5 mmHg(101.3, 215.0) mmHg vs 333.0 mmHg (258.0, 400.0) mmHg, Z=5.79, P<0.001](1 mmHg=0.133 kPa) in patients with RPILD were obviously lower compared with the Non-RPILD individuals.Anti-MDA5 antibody, serum CRP, CEA, NSE, and CYFRA21-1 levels are significantly correlated with RPILD.Serum CYFRA21-1 combined with anti-MDA5 antibody has the highest value in diagnosing PM/DM-RPILD.The sensitivity and specificity are 92.3% and 79.6%, respectively, and the area under the ROC curve is 0.88 ( P<0.001). Conclusions:In PM/DM patients with ILD, increased serum levels of lung cancer tumor markers are related to PM/DM with RPILD.The increase of CYFRA21-1 combined with anti-MDA5 antibodies can better identify the subtypes of PM/DM RPILD.

Correlation Research of Low Density Granulocytes with Interstitial Lung Disease in Dermatomyositis

Measurement of Cytokines and Chemokines and Association with Clinical Severity of Dermatomyositis and Clinically Amyopathic Dermatomyositis.

Cytokines and chemokines in dermatomyositis

Correlation of increased serum leucine-rich α2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective study

Clinical Nomogram Assisting in Discrimination of Juvenile Dermatomyositis-Associated Interstitial Lung Disease.

Correlation of cytokines levels with interstitial lung disease in patients with inflammatory myopathy

Serum Levels of Interleukins and S100A8/A9 Correlate with Clinical Severity in Patients with Dermatomyositis-Associated Interstitial Lung Disease

[A Clinical Analysis of Dermatomyositis with Interstitial Lung Disease in 20 Patients].

Mir-125B, Mir-200C Are Correlated with the Severity of Interstitial Lung Disease in Dermatomyositis/Polymyositis

Serum Interleukin-18 Level is Associated with Disease Activity and Interstitial Lung Disease in Patients with Dermatomyositis

Increased Levels of VCAM-1 in Sera and VLA-4 Expression on Neutrophils in Dermatomyositis with Interstitial Lung Disease

Detection of serum cytokines in patients with dermatomyositis and their clinical significance

[The Clinical Significance of Tumor-associated Antigens in Dermatomyositis Patients with Interstitial Lung Disease].

The molecular mechanism underlying dermatomyositis related interstitial lung disease: evidence from bioinformatic analysis and in vivo validation

Clinical and Serological Feature S of Patients with Dermatomyositis Complicated by Spontaneous Pneumomediastinum

The Predictive Factors and Unfavourable Prognostic Factors of Interstitial Lung Disease in Patients with Polymyositis/dermatomyositis

Factors Associated With Interstitial Lung Disease In Patients With Polymyositis And Dermatomyositis: A Systematic Review And Meta-Analysis

Serum S100A12 Levels Are Correlated with Clinical Severity in Patients with Dermatomyositis-Associated Interstitial Lung Disease.

Clinical significance of tumor markers of lung cancer in interstitial lung disease complicated with polymyositis/dermatomyositis

Serum IL8 and mRNA level of CD11b in circulating neutrophils are increased in clinically amyopathic dermatomyositis with active interstitial lung disease

[Clinical Features and Risk Factors Associated with Interstitial Lung Disease in Patients with Classic Dermatomyositis or Clinical Amyopathic Dermatomyositis].